Botensilimab,balstilimab
agenus
[]
asco #gi23 crc highlights really excited to see new generation of immune checkpoint inhibitors showing good activity in crc #botensilimab #balstilimab while we need to more data, i am hopeful we will break immune cold nature of mss crc in near future 
GI Medical Oncologist | @UPMC Hillman CC/@PittTweet | Clinical investigator- Trialist - Colorectal Cancer| EO-CRC| musician-lead guitar | tweets=my own